As DNA abnormal methylation is one of the mechanisms of tumorigenesis, we hypothesized that HOXB5/6/8/9 are potential therapeutic targets for patients with ccRCC. The gene discussed is HOXB5; the disease is nonpapillary renal cell carcinoma.